Caliper Life Sciences Inc has announced the formation of a scientific advisory board to guide its efforts in automated sample preparation for next generation and third generation sequencing platforms.

Caliper worked closely with leading genome centers to develop the LabChip® XT, which was announced today, and is now expanding its efforts to develop additional solutions for next generation sequencing workflows.

"Although tremendous advances have been made in next and third generation sequencing instrumentation and informatics, there remains an unmet need for high quality sample preparation techniques," said Kevin Hrusovsky, President and CEO, Caliper Life Sciences.

"We are working with the world renowned members of our Sequencing Advisory Board to identify opportunities that improve sequencing workflows while leveraging Caliper’s extensive microfluidics IP estate. We continue to assess strategic opportunities to directly commercialize products and to out-license our microfluidic technology to collaborators."

Source: Caliper Life Sciences